bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic

·2h ago
Share:PostShare

SAN ANTONIO--(BUSINESS WIRE)---- $BIAF #BIAF--bioAffinity announces new Hong Kong patent that protects the proprietary technology behind its noninvasive CyPath Lung diagnostic for lung cancer.

B

Businesswire

Original source

Read full story

kong

Check live status on DownRightNow

Check status →

Related Stories

Science2h ago

ViiV Healthcare Partners with Prevention Access Campaign (PAC) to Celebrate 10 Years of U=U and Look to The Future

DURHAM, N.C.--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced the continuation of its long-standing partnership with Prevention Access Campaign (PAC) – the founding organization behind the Undetectable = Untransmittable (U=U) movement. To celebrate 10 years of U=U, ViiV Healthcare is joining PAC to introduce “Undetectable Voices,” a new digital storytelling and community engagement campaign that builds on

BBusinesswire
Science8h ago

How China’s Asian Games cricket campaign ended without a ball being bowled

China's cricket journey in the Asian Games came to an unforeseen halt, as their quarter-final clash with Bangladesh was called off due to a soaked outfield. Consequently, Bangladesh moved forward to the semi-finals, taking advantage of their superior international ranking. This marked a sudden end to China's third participation in the Asian Games cricket event, a situation governed by tournament rules favouring the higher-ranked team.

TThe Times Of India

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer